Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Frontiers in Immunology|August 22, 2022
CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissuesElisabetta Cribioli, Greta Maria Paola Giordano Attianese, George Coukos, et al.Human Gene Therapy Methods|November 29, 2012
Comparison of different suicide-gene strategies for the safety improvement of genetically manipulated T cellsVirna Marin, Elisabetta Cribioli, Brian Philip, et al.Italian Journal of Pediatrics|September 24, 2011
New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near futureEttore Biagi, Virna Marin, Greta Maria Paola Giordano Attianese, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2011
In vitro comparison of three different chimeric receptor-modified effector T-cell populations for leukemia cell therapyIrene Pizzitola, Valentina Agostoni, Elisabetta Cribioli, et al.Journal for Immunotherapy of Cancer|August 14, 2021
VEGFR-2 redirected CAR-T cells are functionally impaired by soluble VEGF-A competition for receptor bindingEvripidis Lanitis, Paris Kosti, Catherine Ronet, et al.Frontiers in Immunology|October 7, 2022
Enforcing GLUT3 expression in CD8<sup>+</sup> T cells improves fitness and tumor control by promoting glucose uptake and energy storageElisabetta Cribioli, Greta Maria Paola Giordano Attianese, Pierpaolo Ginefra, et al.Nature Biomedical Engineering|April 17, 2023
A lentiviral vector for the production of T cells with an inducible transgene and a constitutively expressed tumour-targeting receptorPatrick Reichenbach, Greta Maria Paola Giordano Attianese, Khaoula Ouchen, et al.Proceedings of the National Academy of Sciences of the United States of America|October 25, 2024
Dual ON/OFF-switch chimeric antigen receptor controlled by two clinically approved drugsGreta Maria Paola Giordano Attianese, Sailan Shui, Elisabetta Cribioli, et al.EJNMMI Research|August 28, 2024
Validation of the C-X-C chemokine receptor 3 (CXCR3) as a target for PET imaging of T cell activationSebastian Martin, Lennard Wendlinger, Béatrice Zitti, et al.British Journal of Haematology|February 26, 2013
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptorSarah Tettamanti, Virna Marin, Irene Pizzitola, et al.Pageof 2